Provider review
A licensed provider reads your health intake and decides if thymosin alpha-1 is right for you.
Immune peptide studied in sepsis trials
A 25 mg vial of thymosin alpha-1, a licensed provider's review and pharmacy shipping in one plan. Alpha-1 is a different peptide from thymosin beta-4 and TB-500, which are not sold here.
From $206/mo with the 3-month plan and auto-refill

How would you like to pay?
Choose your plan
Prescription treatment requires an online medical evaluation. A provider decides whether treatment is appropriate; approval is not guaranteed.
Product details
Your plan
A licensed provider reads your health intake and decides if thymosin alpha-1 is right for you.
A 25 mg vial at 5 mg/mL, prepared by a licensed compounding pharmacy after approval.
Delivered to your door at no added cost.
Auto-refill takes 10% off. Change or cancel future refills anytime.
Worksheets to compare products and read a study, plus a printable decision pack.
Help with your order and delivery when you need it.
How it works
Pick 1, 3, 6 or 12 months. Turn on auto-refill to save 10%.
Answer a private online questionnaire. A licensed provider reviews it.
If prescribed, the pharmacy prepares your thymosin alpha-1 and ships it to you.
Why people choose it
Each card links to the original study, with a tag for the kind of evidence behind it.
In TESTS, a placebo-controlled trial of 1,106 adults with sepsis at 22 centers in China, thymosin alpha-1 did not clearly lower deaths at 28 days.
Read the study Controlled human trialIn Reset-alpha, a smaller randomized sepsis trial, the 120 people who completed it had improved organ-function (SOFA) scores with alpha-1 added to standard care.
Read the study Controlled human trialIn the same 1,106-person trial, safety outcomes did not differ significantly between thymosin alpha-1 and placebo.
Read the studyThe honest version
Thymosin alpha-1 has been tested in randomized human trials, in hospital patients with sepsis. Here is what they found and what they leave open.
See every study we trackTESTS reported 28-day deaths of 23.4% with alpha-1 and 24.1% with placebo. The corrected hazard ratio is 0.97 (95% CI 0.76 to 1.24), with no clear survival benefit.
SourceReset-alpha is a short conference report, with less detail and fewer people than TESTS.
SourceBoth trials studied people in hospital with sepsis. Neither tested routine wellness use.
SourceFAQ
The things people ask most before starting Thymosin Alpha-1.
$249 for one month, or $687 for three months. Auto-refill takes 10% off: $224.10 a month, or $618.30 every three months ($206.10 a month). 6- and 12-month plans cost the same per month as 3 months. Shipping is included.
No. We sell thymosin alpha-1, a different peptide. TB-500 is a fragment of thymosin beta-4, and research on beta-4 or TB-500 does not apply to alpha-1.
25 mg of thymosin alpha-1 at 5 mg/mL in a 5 mL vial. Your provider sets your dose and schedule.
Yes. You complete an online health intake and a licensed provider decides whether thymosin alpha-1 is right for you. Choosing a plan does not guarantee a prescription.
Thymosin alpha-1 in this plan is an injection. Your provider explains your dose, schedule and storage.
The trials so far studied people in hospital with sepsis, not everyday use, so there is no timing data for you. Your provider sets your plan.
No. Compounded thymosin alpha-1 is not FDA approved. Results vary from person to person.
Yes. You can change or cancel future refills anytime.